Abstract
Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Keywords: Hypertension, treatment, compliance, cardiovascular, stroke, ischaemic heart disease, high blood pressure, antihypertensive drugs, Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension), cardiovascular disease, therapeutic inertia, PATIENT COMPLIANCE, antihypertensive drug treat-ment, renin-angiotensin system, white-coat adher-ence, Arterial Hypertension, European Society of Hypertension, European Society of Cardiology, cardiovascular health, Control Hypertension Study
Current Vascular Pharmacology
Title: Improving Patient Compliance with Hypertension Treatment: Mission Possible?
Volume: 8 Issue: 6
Author(s): Marzena Chrostowska and Krzysztof Narkiewicz
Affiliation:
Keywords: Hypertension, treatment, compliance, cardiovascular, stroke, ischaemic heart disease, high blood pressure, antihypertensive drugs, Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension), cardiovascular disease, therapeutic inertia, PATIENT COMPLIANCE, antihypertensive drug treat-ment, renin-angiotensin system, white-coat adher-ence, Arterial Hypertension, European Society of Hypertension, European Society of Cardiology, cardiovascular health, Control Hypertension Study
Abstract: Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Export Options
About this article
Cite this article as:
Chrostowska Marzena and Narkiewicz Krzysztof, Improving Patient Compliance with Hypertension Treatment: Mission Possible?, Current Vascular Pharmacology 2010; 8 (6) . https://dx.doi.org/10.2174/157016110793563799
DOI https://dx.doi.org/10.2174/157016110793563799 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Decreased Cerebral Perfusion and Oxidative Stress Result in Acute and Delayed Cognitive Impairment
Current Neurovascular Research Nitrite as a Physiological Source of Nitric Oxide and a Signalling Molecule in the Regulation of the Cardiovascular System in Both Mammalian and Non-Mammalian Vertebrates
Recent Patents on Cardiovascular Drug Discovery Pharmacological and Surgical Therapy for Primary Postpartum Hemorrhage
Current Pharmaceutical Design Recent Advances in Developing Ophthalmic Formulations: A Patent Review
Recent Patents on Drug Delivery & Formulation Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine ATP-Binding Cassette Efflux Transporters in Human Placenta
Current Pharmaceutical Biotechnology Androgen Deficiency in Aging Male Questionnaire for the Clinical Detection of Testosterone Deficiency in a Population of Black Sub-Saharan African Men with Type 2 Diabetes Mellitus: Is it a Reliable Tool?
Current Diabetes Reviews Hepatotoxic Effect of <i>Lafoensia pacari</i> A. St. Hil. (Lythraceae) on a Diet-Induced Obese Mice Model
Protein & Peptide Letters 5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Attention Deficit Hyperactivity Disorder and N-methyl-D-aspartate (NMDA) Dysregulation
Current Pharmaceutical Design Hypertension in Pregnancy: A Review of Current Guidelines
Current Women`s Health Reviews Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome
Current Pharmacogenomics The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Enhancement of Dissolution Rate of Furosemide Using a Solid Dispersion with D-Glucosamine HCl
Current Pharmaceutical Analysis The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer’s Dementia Using the NACC Database
Current Alzheimer Research Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
Current Drug Targets - Cardiovascular & Hematological Disorders Treatment of Hypertension in Chronic Kidney Disease: Does one Size Fit All? A Narrative Review from a Nephrologist’s Perspective
Current Hypertension Reviews Label-Free Cell Phenotypic Drug Discovery
Combinatorial Chemistry & High Throughput Screening Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action
Current Medicinal Chemistry